Immune checkpoint inhibitors and timing of administration

Lancet Oncol. 2022 Feb;23(2):e56. doi: 10.1016/S1470-2045(22)00009-2.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Humans
  • Immune Checkpoint Inhibitors*
  • Immunotherapy* / adverse effects

Substances

  • Immune Checkpoint Inhibitors